Title: Deep Sequencing Analysis of Human T Cell Lymphotropic Virus Type 1 Long Terminal Repeat 5' Region from Patients with Tropical Spastic Paraparesis/Human T Cell Lymphotropic Virus Type 1-Associated Myelopathy and Asymptomatic Carriers.
Authors: Rego FF, de Oliveira T, Giovanetti M, Galvao-Castro B, Goncalves MS, Alcantara LC..
Journal: AIDS Research and Human Retroviruses,32(3):279-83 (2016)
The aim of this study was to analyze patients by deep sequencing the HTLV-1 LTR region in order to determine if minor and/or major mutations in this promoter region might be associated with TSP/HAM outcome or proviral load or HTLV-1 expression. This study is a cross-sectional analyze of 29 HTLV-1 infected patients with TSP/HAM or asymptomatic carriers. Proviral DNA from those subjects was submitted to a nested-PCR for the HTLV-1 LTR 5' region. The HTLV-1 LTR5' purified products were submitted to deep sequencing using the Ion Torrent? sequencing technology (Life Technologies, Carlsbad, CA).
We found that samples with low proviral load showed more detected minor than the samples with high proviral load. Mutations in 136 positions were found over the 520 bp analyzed fragment of HTLV-1 LTR 5' with at least 1% frequency. Eleven mutations were present in the previously determined major TFBS and in more than a patient, indicating that might be a differential HTLV-1 expression comparing individuals or in different cells from the same individual.
Three mutations were statistically significant using the Fisher non-parametric test between the groups but were not present in previously determined TFBS (G126C/T, G306C and C479T). Those mutations that were not present in previously determined TFBS were statistically significant in this study and most frequent in patients with low proviral load or in asymptomatic carriers. Despite those mutations being not present in previously determined TFBS, one of those mutations (G306C/A) was present in a Sp-1 binding site determined by in silico analyze, and its presence abrogated the site for Sp-1 binding and created a new possible ATF binding site.
KRISP has been created by the coordinated effort of the University of KwaZulu-Natal (UKZN), the Technology Innovation Agency (TIA) and the South African Medical Research Countil (SAMRC).